Precision Medicine Tools to Guide Therapy and Monitor Response to Treatment in a HER-2+ Gastric Cancer Patient: Case Report

Trastuzumab, has played a major role in improving treatment outcomes in HER-2 positive gastric cancer. However, once there is disease progression there is a paucity of evidence for second line therapy. Patient-derived xenografts (PDXs) in combination with liquid biopsies can help guide individual th...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Front Oncol
Autors principals: Aguilar-Mahecha, Adriana, Joseph, Sarah, Cavallone, Luca, Buchanan, Marguerite, Krzemien, Urszula, Batist, Gerald, Basik, Mark
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2019
Matèries:
Oncology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6691136/
https://ncbi.nlm.nih.gov/pubmed/31448226
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2019.00698
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars